RxDoctor Payments Data

Brandy Patterson, MD

Obstetrics & Gynecology · Birmingham, ALNPI 1487771176

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by AMAG Pharmaceuticals, Inc. at 41.6% of the total. Reporting peaked in 2019 at $3,540 and has fallen 57.9% since, to $1,489 in 2025. Among obstetrics & gynecology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,432in general payments, 2019–2025

Across 197 payments — averaging $37.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AMAG Pharmaceuticals, Inc.$3K
  • AbbVie$464
  • Hologic Sales And Service, LLC$431
  • Astellas Pharma US Inc$422
  • Meditrina$361
  • Sumitomo Pharma America, Inc.$323
  • plus $2K from 34 others

What the payments were for

  • Speaking & faculty fees$2,88339%
  • Travel & lodging$4266%
  • Food & beverage$3,82151%
  • Education$3024%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,432 in reported general payments places this provider in the 90th percentile of 537 obstetrics & gynecology providers in Alabama.

See all obstetrics & gynecology providers in Alabama

Medicare billing

Part B allowed, 2024
$5,843
Medicare patients
37
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol81$2,442
ValacyclovirValacyclovir Hcl13$811
Clobetasol Propionate17$683
Ibandronate Sodium15$226
Medroxyprogesterone Acetate12$183
Escitalopram Oxalate15$173
Fluconazole24$151
Lisinopril11$44
Alprazolam23$29

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →